Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
10.57
+0.21 (2.03%)
Feb 18, 2026, 4:00 PM EST - Market closed
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $362.07 million as of February 18, 2026. Its market cap has increased by 35.73% in one year.
Market Cap
362.07M
Enterprise Value
174.27M
1-Year Change
35.73%
Ranking
Category
Stock Price
$10.57
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $362.07M, a decrease of -83.74%. That is a compound annual growth rate of -14.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 354.71M | -22.23% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicycle Therapeutics | 368.34M |
| Adlai Nortye | 367.90M |
| Rocket Pharmaceuticals | 366.33M |
| Monopar Therapeutics | 365.74M |
| Atea Pharmaceuticals | 364.85M |
| Vanda Pharmaceuticals | 364.11M |
| Cybin | 363.26M |
| Greenwich LifeSciences | 361.33M |